{Reference Type}: Journal Article
{Title}: Liposome-based vaccines for minimally or noninvasive administration: an update on current advancements.
{Author}: Aroffu M;Manca ML;Pedraz JL;Manconi M;
{Journal}: Expert Opin Drug Deliv
{Volume}: 20
{Issue}: 11
{Year}: 2023 Jul-Dec 28
{Factor}: 8.129
{DOI}: 10.1080/17425247.2023.2288856
{Abstract}: Vaccination requires innovation to provide effective protection. Traditional vaccines have several drawbacks, which can be overcome with advanced technologies and different administration routes. Over the past 10  years, a significant amount of research has focussed on the delivery of antigens into liposomes due to their dual role as antigen-carrying systems and vaccine adjuvants able to increase the immunogenicity of the carried antigen.<BR>This review encompasses the progress made over the last 10  years with liposome-based vaccines designed for minimally or noninvasive administration, filling the gaps in previous reviews and providing insights on composition, administration routes, results achieved, and Technology Readiness Level of the most recent formulations.<BR>Liposome-based vaccines administered through minimally or noninvasive routes are expected to improve efficacy and complacency of vaccination programs. However, the translation from lab-scale production to large-scale production and collaborations with hospitals, research centers, and companies are needed to allow new products to enter the market and improve the vaccination programs in the future.